Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Trophoblast membrane infusion for unexplained recurrent miscarriage.

P M Johnson1, K V Chia, C A Hart

  • 1Department of Immunology, University of Liverpool, UK.

British Journal of Obstetrics and Gynaecology
|April 1, 1988
PubMed
Summary

A new immunotherapy protocol using placental trophoblast vesicles shows promise for unexplained recurrent miscarriage. This treatment led to a 76% live birth or ongoing pregnancy rate in a clinical study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Arachidonic acid induction of Rho-mediated transendothelial migration in prostate cancer.

British journal of cancer·2014
Same author

Prevalence of Group A beta-haemolytic Streptococcus isolated from children with acute pharyngotonsillitis in Aden, Yemen.

Tropical medicine & international health : TM & IH·2014
Same author

Confusing medical terms: disease that may or may not exist.

QJM : monthly journal of the Association of Physicians·2013
Same author

Ligand-independent activation of EphA2 by arachidonic acid induces metastasis-like behaviour in prostate cancer cells.

British journal of cancer·2012
Same author

Multilocus sequence typing of human and canine C. upsaliensis isolates.

Veterinary microbiology·2012
Same author

Diagnostic efficacy of activated partial thromboplastin time waveform and procalcitonin analysis in pediatric meningococcal sepsis.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·2011

Area of Science:

  • Immunology
  • Reproductive Medicine
  • Obstetrics

Background:

  • Unexplained recurrent miscarriage (URM) poses a significant challenge in reproductive medicine.
  • Current treatment options for URM are limited and often ineffective.
  • Immunotherapy is being explored as a potential therapeutic strategy for URM.

Purpose of the Study:

  • To describe a novel immunotherapy protocol for URM.
  • To evaluate the clinical efficacy of this new protocol.

Main Methods:

  • The protocol involves a single intravenous infusion of isolated placental trophoblast plasma membrane vesicle preparations.
  • Clinical experience with 21 patients undergoing this treatment was documented.

Main Results:

Related Experiment Videos

  • A total of 16 out of 21 (76%) patients achieved a live birth or were pregnant at over 28 weeks gestation.
  • This suggests a high success rate for the novel immunotherapy.

Conclusions:

  • The described immunotherapy protocol using placental trophoblast vesicles is a promising approach for managing unexplained recurrent miscarriage.
  • Further research is warranted to confirm these findings and explore the underlying mechanisms.